Contezolid: First Approval

Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity

(2021) Wen Wang et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms

(2020) Despoina Koulenti et al.   Microorganisms

Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients

(2020) Li Li et al.   CLINICAL THERAPEUTICS

In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from US and Europe

(2020) Cecilia G. Carvalhaes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis

(2018) Carolyn Shoen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects

(2018) Xiaojie Wu et al.   CLINICAL THERAPEUTICS

In VivoAntibacterial Activity of MRX-I, a New Oxazolidinone

(2014) Cong-Ran Li et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY